This inventor holds 2 USPTO granted patents. Top assignee: Rhinonase, Inc.. Active years: 2019-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2020
Title: The Innovative Contributions of Jeffrey B. Harris
Introduction
Jeffrey B. Harris is a notable inventor based in La Canada, California. He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of nasal irrigation. With a total of two patents to his name, Harris has focused on developing innovative solutions for treating sinusitis and related conditions.
Latest Patents
Harris's latest patents include antibiotic compositions for nasal irrigation and methods. These patents provide pharmaceutical formulations, nasal irrigation fluids, sachets, and kits that comprise cephalosporin antibiotics. The inventions also detail methods for the topical treatment of sinusitis, methods for delivering these formulations to the sinuses, and techniques for coating the sinuses. Additionally, they address methods for disrupting and penetrating biofilms in the sinuses, showcasing Harris's commitment to advancing medical treatments.
Career Highlights
Throughout his career, Harris has been associated with Rhinonase, Inc., where he has been able to apply his expertise in developing innovative medical solutions. His work has contributed to the advancement of treatments that improve patient outcomes in sinus-related health issues.
Collaborations
Harris has collaborated with talented individuals such as Kambiz Yadidi and Amanda Quiroga. These partnerships have fostered a creative environment that encourages the development of groundbreaking medical innovations.
Conclusion
Jeffrey B. Harris's contributions to the field of pharmaceutical formulations, particularly in nasal irrigation, highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a deep understanding of medical needs and a commitment to addressing them effectively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile